One of the most astonishing and promising discoveries related to Alzheimer’s disease is the realization that amyloid plaque and tau buildup begins forming many decades before the first clinical symptoms appear, meaning that AD is present in the brain long before a patient begins to suffer any deterioration of function. The best way to fight AD - the answer we are racing toward - will be administering medication or other therapies long before the patient experiences any of the disease’s devastating symptoms, preventing rather than treating it.
Experts at Mount Sinai are tirelessly hunting these “biomarkers of disease” by using the latest and most innovative approaches.